Clinical Trial Update: Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on an autologous neoantigen-specific T-cell therapy for advanced hepatocellular carcinoma; the Phase 1/2 study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Autologous neoantigen-specific T-cell therapy

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: RECRUITING